James J Bull

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Silver Nanoparticles

Biofilm Formation

Staphylococcus Aureus

Top Venues

Expert review of vaccines

PLoS computational biology

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

James J Bull, Scott L Nuismer, Christopher H Remien, Megan E Griffiths, Morie A Gertz
Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect. Expert review of vaccines 23 (1) (2024)
James J Bull, Scott L Nuismer, Christopher H Remien, Megan E Griffiths, Morie A Gertz
Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect. Expert review of vaccines 23 (1) (2024)
James J Bull, Scott L Nuismer, Christopher H Remien, Megan E Griffiths, Morie A Gertz
Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect. Expert review of vaccines 23 (1) (2024)
James J Bull, Scott L Nuismer, Christopher H Remien, Megan E Griffiths, Morie A Gertz
Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect. Expert review of vaccines 23 (1) (2024)
Jeremy R Ellis, James J Bull, Paul Andrew Rowley
Fungal Glycoside Hydrolases Display Unique Specificities for Polysaccharides and Staphylococcus aureus Biofilms. Microorganisms 11 (2) (2023)
Jeremy R Ellis, James J Bull, Paul Andrew Rowley
Fungal Glycoside Hydrolases Display Unique Specificities for Polysaccharides and Staphylococcus aureus Biofilms. Microorganisms 11 (2) (2023)
Jeremy R Ellis, James J Bull, Paul Andrew Rowley
Fungal Glycoside Hydrolases Display Unique Specificities for Polysaccharides and Staphylococcus aureus Biofilms. Microorganisms 11 (2) (2023)
Jeremy R Ellis, James J Bull, Paul Andrew Rowley
Fungal Glycoside Hydrolases Display Unique Specificities for Polysaccharides and Staphylococcus aureus Biofilms. Microorganisms 11 (2) (2023)
James J Bull, Holly A Wichman, Stephen M Krone
Modeling the Directed Evolution of Broad Host Range Phages. Antibiotics (Basel, Switzerland) 11 (12) (2022)
James J Bull, Holly A Wichman, Stephen M Krone
Modeling the Directed Evolution of Broad Host Range Phages. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Forest Cook, James J Bull, Richard Gomulkiewicz
Gene drive escape from resistance depends on mechanism and ecology. Evolutionary applications 15 (5) (2022)
James J Bull, Morie A Gertz
Which 'imperfect vaccines' encourage the evolution of higher virulence? Evolution, medicine, and public health 10 (1) (2022)
Sylvain Blois, Benjamin M Goetz, James J Bull, Christopher S Sullivan
Interpreting and de-noising genetically engineered barcodes in a DNA virus. PLoS computational biology 18 (11) (2022)
Morie A Gertz, Hasan Ahmed, James J Bull
Directed attenuation to enhance vaccine immunity. PLoS computational biology 17 (2) (2021)
Scott L Nuismer, Nathan C Layman, Alec James Redwood, Baca Chan, James J Bull
Methods for measuring the evolutionary stability of engineered genomes to improve their longevity. Synthetic biology (Oxford, England) 6 (1) (2021)
Nathan C Layman, Beth M Tuschhoff, Andrew J Basinski, Christopher H Remien, James J Bull, Scott L Nuismer
Suppressing evolution in genetically engineered systems through repeated supplementation. Evolutionary applications 14 (2) (2020)
James J Bull, Scott L Nuismer, Morie A Gertz
Recombinant vector vaccine evolution. PLoS computational biology 15 (7) (2019)